Cancer & Therapeutics

Cancer Therapeutics is to tackle the challenge of tumor heterogeneity, cancer evolution and resistance to drug treatments which include an ever-increasing array of tools at the disposal of clinicians in their treatment of this disease. It has endured a paradigm shift away from the traditional cytotoxic drugs towards the targeting of proteins intimately involved in driving the cancer phenotype. Cancer therapeutics has pursued the discovery and development of HSP90 inhibitors, as one way of preventing or overcoming drug resistance. All Anticancer agents act by depressing cell multiplication or normal functioning, DNA synthesis and by blocking or changing RNA and protein metabolite.


    Related Conference of Cancer & Therapeutics

    October 26-26, 2021

    3rd Global Meeting on Oncology and Radiology

    Amsterdam, Netherlands

    Cancer & Therapeutics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in